JAIMIE FAST: Open Payments
NPI 1134742802 · LANSING, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,175 in 170 payments from 19 companies in 2025. Trend: 2023 $1,365 · 2024 $2,400 · 2025 $3,175
Food & beverage: $3,066Education: $109
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 31 | $690 |
| Galderma Laboratories, L.P. | 27 | $421 |
| Organon LLC | 21 | $324 |
| Amgen Inc. | 12 | $258 |
| UCB, Inc. | 8 | $249 |
| Incyte Corporation | 11 | $209 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 12 | $190 |
| Novartis Pharmaceuticals Corporation | 20 | $158 |
| E.R. Squibb & Sons, L.L.C. | 5 | $126 |
| Arcutis Biotherapeutics, Inc. | 6 | $112 |
Products named: TREMFYA, NEMLUVIO, Otezla, Bimzelx, VTAMA, DUPIXENT, OPZELURA, COSENTYX.
Industry payments across MI — which companies pay providers there.
